Gateshead Health NHS Foundation Trust: The primary aim of the study is to investigate if people with borderline (subclinical) hypothyroidism (TSH > 6.0 MlU/L and normal thyroid hormone levels) at baseline have a higher
Data-sharing agreement from NHS Digital registers of approved data releases, 2014–2019. Evidence status: source reported.
- Organisation
- Gateshead Health NHS Foundation Trust
- Source reference
- DARS-NIC-148059-8KY1S-v0.0
- Jurisdiction
- England
- Licence
- Open Government Licence v3.0, subject to NHS England terms and exclusions
The primary aim of the study is to investigate if people with borderline (subclinical) hypothyroidism (TSH > 6.0 MlU/L and normal thyroid hormone levels) at baseline have a higher cardiovascular risk and mortality (all cause and cardiovascular) after 30+ years of follow up. The secondary outcome is to investigate the natural history and time course of borderline (subclinical) hypothyroidism (with or without positive anti microsomal antibodies) over the extended 30+ years follow up period? In people with borderline (subclinical) hyperthyroidism at the 20 year follow up, what is the incidence of
- Register reference
- DARS-NIC-148059-8KY1S-v0.0
- Agreement period
- not published to no end date published
- For commercial purposes (as marked in the register)
- Not stated
- Release files listed by NHS England
- 8
Data approved
- MRIS - Cause of Death Report
- MRIS - Cohort Event Notification Report
- MRIS - Scottish NHS / Registration
- MRIS - Flagging Current Status Report
Objective, as published
The primary aim of the study is to investigate if people with borderline (subclinical) hypothyroidism (TSH > 6.0 MlU/L and normal thyroid hormone levels) at baseline have a higher cardiovascular risk and mortality (all cause and cardiovascular) after 30+ years of follow up. The secondary outcome is to investigate the natural history and time course of borderline (subclinical) hypothyroidism (with or without positive anti microsomal antibodies) over the extended 30+ years follow up period? In people with borderline (subclinical) hyperthyroidism at the 20 year follow up, what is the incidence of overt hyperthyroidism over the ensuing 10 years of what is the cardiovascular outcome?
Expected benefits, as published
To be completed by applicant
Source: https://webarchive.nationalarchives.gov.uk/ukgwa/2019/http://content.digital.nhs.uk/media/23861/Release-Register-December-16---February-17/xls/Release_Register__December_16_-_February_17.xlsx. Captured 2026-10-30.
Limitations: Agreement as recorded in an NHS Digital register of approved data releases (2014–2019), retrieved from the UK Government Web Archive. That register lists releases made in its period and the agreement's purpose statement as it then stood; it gives no agreement dates, and the agreement may have changed since. Imported only where a paper quotes a reference no current register holds.